ArticleTransplant infectious disease : an official journal of the Transplantation Society

Preemptive Rituximab for Epstein-Barr Virus Reactivation After Hematopoietic Cell Transplantation: Necessary for All?

Anna Beatriz Coelho de Souza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.